References
- Abebaw W, M Kibret, B Abera (2014). Prevalence and risk factors of H. pylori from dyspeptic patients in northwest Ethiopia: a hospital based cross-sectional study. Asian Pac J Cancer Prev, 15, 4459-63. https://doi.org/10.7314/APJCP.2014.15.11.4459
- Asaka M, Kato M, Sakamoto N (2014). Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol, 49, 1-8 https://doi.org/10.1007/s00535-013-0897-8
- Basiri Z, R Safaralizadeh, MJ Bonyadi, et al (2014). Helicobacter pylori vacA d1 genotype predicts risk of gastric adenocarcinoma and peptic ulcers in northwestern Iran. Asian Pac J Cancer Prev, 15, 1575-9. https://doi.org/10.7314/APJCP.2014.15.4.1575
- Demirel BB, BE Akkas, GU Vural (2013). Clinical factors related with Helicobacter pylori infection--is there an association with gastric cancer history in first-degree family members? Asian Pac J Cancer Prev, 14, 1797-02. https://doi.org/10.7314/APJCP.2013.14.3.1797
- Chua TS, Fock KM, Chan YH, et al (2002). Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma. Helicobacter, 7, 257-64. https://doi.org/10.1046/j.1523-5378.2002.00089.x
- Fock KM, Talley N, Moayyedi P, et al (2008). Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol, 23, 351-65. https://doi.org/10.1111/j.1440-1746.2008.05314.x
- Hazell SL, Hennessy WB, Borody TJ, et al (1987). Campylobacter pyloridis gastritis. II. Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol, 82, 297-301.
- Huang J-Q, Sridhar S, Chen Y, et al (1998). Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology, 1148, 1167-9.
- IARC (1994). "Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994." IARC Monogr Eval Carcinog Risks Hum, 61, 1-241.
- Karami N, Talebkhan Y, Saberi S, et al (2013). Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer. Asian Pac J Cancer Prev, 14, 1813-7. https://doi.org/10.7314/APJCP.2013.14.3.1813
- Lin WL, Sun JL, Chang SC, et al (2014). Factors predicting survival of patients with gastric cancer. Asian Pac J Cancer Prev, 15, 5835-8. https://doi.org/10.7314/APJCP.2014.15.14.5835
- Mahachai V, Vilaichone RK (2011). Current Status of Helicobacter pylori Infection in Thailand. Helicobacter Res 15, 38-44.
- Martin-de Argila C, Boixeda D, Redondo C, et al (1997). Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand J Gastroenterol, 32, 303-7. https://doi.org/10.3109/00365529709007676
- Nomura A, Stemmermann GN, Chyou P-H, et al (1991). Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med, 325, 1132-6. https://doi.org/10.1056/NEJM199110173251604
- Ono S, Kato M, Suzuki M, et al (2012). Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion, 86, 59-65. https://doi.org/10.1159/000339176
- Parsonnet J, Friedman GD, Vandersteen DP, et al (1991). Helicobacter pylori infection and the risk of gastric cancer. N Engl J Med, 325, 1127-31. https://doi.org/10.1056/NEJM199110173251603
- Robey-Cafferty SS1, Ro JY, Cleary KR (1989). The prevalence of Campylobacter pylori in gastric biopsy from cancer patients. Mod Pathol, 2, 473-476.
- Sano H, Goto R, Hamashima C (2014). What is the most effective strategy for improving the cancer screening rate in Japan? Asian Pac J Cancer Prev, 15, 2607-12. https://doi.org/10.7314/APJCP.2014.15.6.2607
- Talley NJ, Zinsmeister AR, Weaver A, et al (2001). Gastric carcinoma and Helicobacter pylori infection. J Natl Cancer Inst, 83, 1734-9.
- Uemura N, S Okamoto, S Yamamoto, et al (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 345, 784-9. https://doi.org/10.1056/NEJMoa001999
- Vilaichone RK, Mahachai V, Graham DY (2006). Helicobacter pylori: Diagnosis and management. Gastroenterol Clin North Am, 35, 229-47. https://doi.org/10.1016/j.gtc.2006.03.004
- Vilaichone RK, Mahachai V, Kositchaiwat C, Graham DY, Yamaoka Y (2003). Relation between seroreactivity to lowmolecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol, 10, 1025-8.
Cited by
- Effects of the CYP2C19 Genetic Polymorphism on Gastritis, Peptic Ulcer Disease, Peptic Ulcer Bleeding and Gastric Cancer vol.15, pp.24, 2014, https://doi.org/10.7314/APJCP.2014.15.24.10957
- Genotyping of Peroxisome Proliferator-Activated Receptor gamma in Iranian Patients with Helicobacter pylori Infection vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5219
- Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.6089
- Late Stage and Grave Prognosis of Esophageal Cancer in Thailand vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1747
- Antibiotic Resistant Pattern of Helicobacter Pylori Infection Based on Molecular Tests in Laos vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.285
- Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand vol.94, pp.4, 2016, https://doi.org/10.4269/ajtmh.15-0449
- Helicobacter pylori virulence genes of minor ethnic groups in North Thailand vol.9, pp.1, 2017, https://doi.org/10.1186/s13099-017-0205-x